- NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
- NeoGenomics Reports First Quarter 2024 Results
- NeoGenomics Announces Senior Leadership Promotions
- NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
- NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
More ▼
Key statistics
On Friday, Neogenomics Inc (NEO:NAQ) closed at 13.71, 24.30% above the 52 week low of 11.03 set on Oct 04, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.09 |
---|---|
High | 14.26 |
Low | 13.64 |
Bid | 13.59 |
Offer | 14.34 |
Previous close | 14.00 |
Average volume | 505.13k |
---|---|
Shares outstanding | 127.71m |
Free float | 126.21m |
P/E (TTM) | -- |
Market cap | 2.00bn USD |
EPS (TTM) | -0.6698 USD |
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼